Electrocorticography is not a disease itself, but a specialized diagnostic procedure used in medicine to record electrical activity directly from the surface of the brain. This invasive monitoring technique plays a crucial role in helping doctors identify the source of seizures in patients with epilepsy that does not respond to medication, and it also assists surgeons in mapping important brain areas before performing surgical procedures.

How Brain Activity Monitoring Helps in Epilepsy Care

When someone experiences seizures that cannot be controlled with medications, doctors need to find out exactly where in the brain these seizures begin. Electrocorticography, often shortened to ECoG, is a specialized recording method that allows doctors to see electrical signals coming from the brain with much greater clarity than traditional methods.^[1] Unlike a standard electroencephalogram (EEG), which measures brain activity through electrodes placed on the scalp outside the skull, ECoG involves placing electrodes directly on the exposed surface of the brain during a surgical procedure.^[2]

This procedure has been an important tool in epilepsy treatment since the 1950s, when pioneering neurosurgeons Wilder Penfield and Herbert Jasper at the Montreal Neurological Institute developed it as part of the Montreal procedure, a surgical approach for treating severe epilepsy.^[1] The main goal of using ECoG is to help doctors accurately locate the epileptogenic zone—the specific region of the brain where seizures originate—so they can decide whether surgically removing that area might help the patient. The procedure also helps identify critical areas of the brain that control speech, movement, and sensation, which surgeons must avoid damaging during any operation.^[1]

ECoG is not used for everyone with epilepsy. It is reserved for patients whose seizure location cannot be identified clearly through non-invasive tests like standard EEG and magnetic resonance imaging (MRI).^[2] When these simpler tests do not provide enough information, doctors may recommend ECoG monitoring to gather more detailed data before making treatment decisions.

Understanding the ECoG Procedure

The electrocorticography procedure requires surgery to expose the surface of the brain. First, a neurosurgeon performs a craniotomy, which means removing a section of the skull to access the brain.^[1] This is an invasive procedure, meaning it involves cutting into the body, and it carries the risks associated with any brain surgery. Once the brain surface is exposed, the surgeon places electrode arrays—either flat grids containing multiple electrode contacts or narrow strips with several electrodes arranged in a row—directly onto the cerebral cortex, the outer layer of the brain.^[2]

The electrodes used in ECoG are typically made of platinum or platinum-iridium materials and are arranged in various configurations depending on the patient’s needs.^[4] A common setup includes rectangular grids, such as a 6×8 array, or linear strips containing several electrodes spaced at regular intervals, typically 10 millimeters apart.^[2] Some patients may also receive depth electrodes—cylindrical leads that penetrate into deeper brain structures—either alone or in combination with surface electrodes. This combined approach is sometimes called stereoelectroencephalography or sEEG.^[2]

The surgery to place the electrodes typically lasts several hours and is most commonly performed under general anesthesia.^[2] The number and placement of electrodes are customized for each patient based on information gathered before surgery about where seizures might be starting. After the electrodes are in place, the patient remains in the hospital for continuous monitoring, usually for three to seven days, though sometimes longer if necessary.^[2]

After the monitoring period is complete, the electrodes are removed in the operating room. Sometimes, if the data clearly identifies the seizure source and it is safe to do so, the surgeon may remove the problematic brain tissue during the same operation.^[2] The information gathered creates a detailed map showing not only where seizures start but also where important brain functions like speech and movement are located, helping surgeons plan the safest and most effective treatment approach.

What Makes ECoG Different from Other Brain Monitoring Methods

Electrocorticography offers several advantages over standard EEG recordings taken from the scalp. The main difference lies in how close the electrodes are to the source of electrical activity. When brain cells communicate, they generate tiny electrical signals. In standard EEG, these signals must travel through several layers—the brain tissue itself, the cerebrospinal fluid that surrounds the brain, three protective membranes called meninges, the skull bone, and finally the scalp—before reaching the recording electrodes.^[1] The skull, in particular, has very low electrical conductivity, which means it blocks and weakens the signals significantly.

With ECoG, the electrodes are placed much closer to the source, directly on the brain surface underneath the outer membrane called the dura mater.^[1] This proximity means the electrical signals do not have to pass through the skull, so they remain much stronger and clearer. As a result, ECoG provides much better spatial resolution—the ability to pinpoint exactly where signals are coming from—compared to scalp EEG. This high spatial resolution is critical for presurgical planning because it allows doctors to identify very precisely which small areas of brain tissue are causing problems.^[1]

Research has shown that ECoG has a temporal resolution of approximately 5 milliseconds—meaning it can detect changes in brain activity within five-thousandths of a second—and spatial resolution as precise as 1 to 100 micrometers when using certain electrode types.^[1] Studies examining how far ECoG signals spread found that they actually represent quite local brain activity. One research study using monkeys found that the spatial spread of ECoG was surprisingly limited, with a diameter of only about 3 millimeters, which is only three times larger than the spread captured by even smaller microelectrodes.^[3][5] This means ECoG provides information about a relatively small, specific area of the brain, making it very useful for identifying seizure sources accurately.

The signals recorded by ECoG reflect synchronized activity from large groups of neurons, particularly from specialized brain cells called pyramidal cells in the cortex.^[1] These signals are called local field potentials, which represent the combined electrical activity of hundreds of thousands of neurons working together in a small region.^[6]

Standard Treatment Approaches When ECoG is Used

Electrocorticography itself is not a treatment—it is a diagnostic tool used to guide treatment decisions for patients with drug-resistant epilepsy. When medications fail to control seizures, which happens in about one-third of epilepsy patients, surgical options become important considerations.^[2] The standard treatment pathway typically begins with trying various anti-seizure medications, adjusting doses, and sometimes combining different drugs to achieve seizure control.

When medications prove ineffective, doctors perform extensive evaluations using non-invasive tests. These include prolonged video-EEG monitoring, where patients are recorded on video while EEG monitors their brain activity, often for several days. Doctors also use brain imaging studies such as MRI to look for structural abnormalities that might be causing seizures.^[2] These non-invasive approaches help narrow down the seizure location, but they sometimes cannot provide enough detail for surgical planning.

This is where ECoG becomes part of the standard clinical approach. After ECoG monitoring successfully identifies the seizure focus, several treatment options may be considered. The most common surgical treatment is resection, where the surgeon removes the specific area of brain tissue where seizures originate.^[1] This is most often performed when seizures come from the temporal lobe of the brain, which is the most common location for epilepsy that can be treated surgically.

A newer alternative to traditional open surgery for temporal lobe epilepsy is laser interstitial thermal therapy (LITT), where a laser precisely targets and destroys the small area of brain tissue causing seizures.^[2] This minimally invasive approach offers advantages in recovery time and surgical risk for appropriate candidates.

When seizures originate outside the temporal lobe, surgeons typically remove just the problem area identified by ECoG and other tests. In children with certain types of severe epilepsy, other surgical options may be considered. These include corpus callosotomy, where the bundle of nerve fibers connecting the brain’s two hemispheres is partially or completely severed to prevent seizures from spreading; hemispherectomy, where one side of the cerebral cortex is removed; or functional hemispherectomy, where the seizure-generating side of the brain is disconnected from other brain regions without actual removal of tissue.^[2]

Throughout the monitoring period and after surgery, patients continue taking their prescribed anti-seizure medications. These medications may be reduced during monitoring specifically to allow seizures to occur for recording purposes, but medication remains an important part of long-term epilepsy management even for patients who undergo surgery.^[2]

Advanced Technologies and Research Applications

While ECoG was originally developed for epilepsy care, researchers have expanded its applications considerably. Scientists now use ECoG to study normal brain function, investigate how the brain processes sensory information, and explore cognitive functions like memory, attention, and decision-making.^[5] Because patients undergoing ECoG monitoring are usually awake and alert during much of the recording period, they can participate in various research tasks while their brain activity is being measured with exceptional precision.

One particularly important area of research involves brain-computer interfaces (BCIs), systems that allow direct communication between the brain and external devices.^[6] ECoG has emerged as a promising approach for BCIs because it provides much better signal quality than scalp EEG while being less invasive than methods requiring electrodes to penetrate deep into brain tissue. Researchers are investigating how ECoG signals could help paralyzed individuals control robotic limbs, computer cursors, or communication devices using only their thoughts.

A particularly interesting ECoG signal that researchers focus on is called high gamma power (HGP), which refers to electrical activity in the frequency range of 70 to 190 hertz. This high-frequency activity has a very good signal-to-noise ratio and appears to reflect the combined firing patterns of groups of neurons directly beneath the electrode.^[7] This makes HGP particularly valuable for understanding which brain areas are active during specific tasks or cognitive processes.

Recent technological advances have made ECoG monitoring more practical and patient-friendly. Researchers have developed portable wireless ECoG systems that allow patients greater mobility during monitoring rather than being tethered to recording equipment by wires.^[11] These systems use modern wireless communication technologies like Bluetooth to transmit brain signals to computers or even cell phones, where doctors can monitor the data remotely. One experimental system demonstrated the ability to record from 32 channels simultaneously with high sampling rates while maintaining low power consumption, all in a portable package that patients could carry with them.^[11]

Clinical Applications and Research in Treatment Assessment

Beyond identifying seizure sources, ECoG has found applications in assessing treatment effectiveness. One innovative use involves a device called the Responsive Neurostimulation System (RNS), which was approved as an additional therapy for drug-resistant focal epilepsy.^[10][12] This system continuously records ECoG activity from implanted electrodes, automatically detects patterns that signal an impending seizure, and delivers targeted electrical stimulation to stop seizures before they fully develop.

Research using the RNS system has revealed interesting insights about how to measure treatment effectiveness. Traditional methods of assessing epilepsy treatments rely on patients reporting their seizures, but many seizures go unnoticed by patients, particularly small seizures or those occurring during sleep. Studies comparing patient-reported seizure frequencies with ECoG-detected seizure frequencies found significant discrepancies.^[10][12] One study found that when using ECoG recordings as the baseline for counting seizures, patients showed much greater improvement than when using self-reported seizure counts. At three months, patients showed an 82% reduction in seizures based on ECoG data compared to only an 11% increase based on self-reports; at one year, ECoG data showed a 75% reduction compared to 58% based on self-reports.^[12]

This discrepancy occurs because patients often underreport their seizures—either because seizures go unnoticed or because patients have difficulty accurately counting and remembering all seizure events. Using ECoG to establish a true seizure frequency baseline provides a more accurate assessment of treatment effectiveness.

Researchers have also investigated whether certain characteristics of ECoG recordings can predict which patients will respond better to treatments. One study examining patients with temporal lobe epilepsy treated with the RNS system identified various ECoG characteristics that correlated with clinical outcomes.^[2] These biomarkers—measurable indicators found in the electrical signals—may eventually help doctors predict how well individual patients will respond to specific epilepsy treatments, allowing more personalized treatment planning.

Safety Considerations and Limitations

Because ECoG requires a craniotomy and electrode placement on the brain surface, it carries inherent risks associated with neurosurgery. These include the risk of infection, bleeding, swelling, and potential damage to brain tissue. The procedure requires patients to remain hospitalized for several days with electrodes implanted in their head, which can be uncomfortable and restricts normal activities.

During the monitoring period, patients must follow specific guidelines to protect the equipment and maintain recording quality. They cannot shower or wash their hair while electrodes are in place, as moisture could loosen electrodes from the scalp or damage equipment. Physical activity must be limited to prevent excessive sweating or accidental electrode displacement. Patients should avoid touching or tampering with the electrodes, even if itching occurs.^[15] Certain electronics should be used cautiously, as charging devices near the recording equipment can create electrical interference that corrupts the data.^[15]

The removal of electrodes at the end of monitoring requires another trip to the operating room. Complications can arise if electrodes become trapped by replaced bone or fixation hardware, or if the subcutaneous tunnel where electrode wires exit is too tight. Careful surgical technique during initial placement helps prevent these complications, including making sure sufficient bone is removed where electrodes exit and avoiding placement of fixation hardware too close to electrode wires.^[20] A cerebrospinal fluid leak can develop at the exit point if proper closure techniques are not used.^[20]

Despite these limitations, ECoG remains an essential tool when non-invasive methods cannot provide adequate information for treatment planning. The benefits of accurately identifying seizure sources and safely planning surgical treatment generally outweigh the risks for carefully selected patients who have exhausted other diagnostic options.

Most Common Treatment Methods

• Surgical Resection
  • Removal of the specific brain area where seizures originate, identified through ECoG mapping
  • Most commonly performed for temporal lobe epilepsy, the most frequent surgical target
  • Areas outside the temporal lobe may also be resected when ECoG identifies them as seizure sources
• Laser Interstitial Thermal Therapy (LITT)
  • Minimally invasive alternative to traditional open surgery for certain epilepsy cases
  • Uses laser energy to precisely target and destroy small areas of brain tissue causing seizures
  • Particularly useful for temporal lobe epilepsy when anatomy is suitable
• Corpus Callosotomy
  • Surgical procedure where nerve fibers connecting the brain’s two hemispheres are partially or completely severed
  • Prevents seizures from spreading from one side of the brain to the other
  • Often considered for children with severe epilepsy when seizures cannot be controlled by other methods
• Hemispherectomy and Functional Hemispherectomy
  • Removal of one side of the cerebral cortex or disconnection of one hemisphere from the rest of the brain
  • Reserved for severe cases of childhood epilepsy where one hemisphere generates most seizures
  • Functional hemispherectomy disconnects the seizure-generating hemisphere without tissue removal
• Responsive Neurostimulation (RNS)
  • Implantable device that continuously monitors brain activity through ECoG electrodes
  • Automatically detects seizure patterns and delivers electrical stimulation to interrupt seizures
  • Approved as adjunctive therapy for drug-resistant focal epilepsy